Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease
- 1 January 2003
- journal article
- review article
- Published by Wiley in BioFactors
- Vol. 18 (1-4) , 153-161
- https://doi.org/10.1002/biof.5520180218
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing ratMechanisms of Ageing and Development, 1995
- Selenium deficiency and decreased Coenzyme Q levelsMolecular Aspects of Medicine, 1994
- Bioavailability of four oral Coenzyme Q10 formulations in healthy volunteersMolecular Aspects of Medicine, 1994
- Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamateEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Relations Between Tocopherol Depletion and Coenzyme Q During Lipid Peroxidation in rat Liver MitochondriaFree Radical Research, 1994
- Decreased Ubiquinone Levels in Tissues of Rats Deficient in SeleniumBiochemical and Biophysical Research Communications, 1993
- Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Tissue coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory ratMechanisms of Ageing and Development, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983